Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: A 10 Year Experience

BACKGROUND: The FDA currently recommends at least 4 hours of recipient monitoring to detect early infusion reactions; recent catastrophic reactions to “first in man” biological agents have emphasized the importance of this rule for initial studies of new products. The value of such monitoring for be...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cruz, Conrad Russell, Hanley, Patrick J., Liu, Hao, Torrano, Vicky, Lin, Yu-Feng, Arce, James A., Gottschalk, Stephen, Savoldo, Barbara, Dotti, Gianpietro, Louis, Chrystal U., Leen, Ann M., Gee, Adrian P., Rooney, Cliona M., Brenner, Malcolm K., Bollard, Catherine M., Heslop, Helen E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2914831/
https://ncbi.nlm.nih.gov/pubmed/20429793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653241003709686
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak